Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Clin Gastroenterol ; 53(6): 464-469, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-29952857

RESUMO

GOALS: We aim to describe the efficacy, safety profile, and variables associated with survival in patients with hepatocellular carcinoma (HCC) treated with sorafenib in South America. BACKGROUND: Sorafenib has been shown to improve survival in patients with advanced HCC. There are few data on sorafenib use for HCC in South America. STUDY: We performed a retrospective analysis of HCC cases treated with sorafenib from 8 medical centers in 5 South American countries, between January 2010 and June 2017. The primary endpoint was overall survival (OS), which was defined as time from sorafenib initiation to death or last follow-up. Risk factors for decreased OS were assessed using Cox proportional hazard regression and log-rank tests. RESULTS: Of 1336 evaluated patients, 127 were treated with sorafenib and were included in the study. The median age of individuals was 65 years (interquartile range, 55 to 71) and 70% were male individuals. Median OS in all patients was 8 months (interquartile range, 2 to 17). Variables associated with survival on multivariate analysis were platelets >/<250,000 mm (2 vs. 8 mo, P=0.01) and Barcelona Clinic Liver Cancer (BCLC) stage (A/B, 13 vs. C/D, 6 mo; P=0.04). In a subanalysis of patients with BCLC stage C, platelets >/<250,000 mm were also independently associated with survival (2 vs. 5.5 mo, P=0.03). Patients lived longer if they experienced any side effects from sorafenib use (11 vs. 2 mo, P=0.009). Patients who stopped sorafenib because of side effects had shorter survival compared with patients who were able to tolerate side effects and continue treatment (7.5 vs. 13 mo, P=0.01). CONCLUSIONS: Pretreatment elevation of platelets and advanced BCLC stage were independently associated with poor survival on sorafenib in a South American cohort.


Assuntos
Antineoplásicos/administração & dosagem , Carcinoma Hepatocelular/tratamento farmacológico , Neoplasias Hepáticas/tratamento farmacológico , Sorafenibe/administração & dosagem , Idoso , Antineoplásicos/efeitos adversos , Plaquetas/metabolismo , Carcinoma Hepatocelular/patologia , Estudos de Coortes , Feminino , Humanos , Neoplasias Hepáticas/patologia , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Estudos Retrospectivos , Fatores de Risco , Sorafenibe/efeitos adversos , América do Sul , Análise de Sobrevida , Taxa de Sobrevida , Resultado do Tratamento
2.
BMJ Open ; 13(9): e070456, 2023 09 27.
Artigo em Inglês | MEDLINE | ID: mdl-37758670

RESUMO

OBJECTIVES: To evaluate the efficacy of antituberculosis therapy on pregnancy outcomes in infertile women with genital tuberculosis. DESIGN: Systematic review. DATA SOURCES: We searched in PubMed/MEDLINE, CENTRAL and EMBASE up to 15 January 2023. Additionally, we manually search the reference lists of included studies. ELIGIBILITY CRITERIA: We included randomised controlled trials (RCT), non-RCTs (non-RCT) and cohort studies that evaluated the effects of antituberculosis treatment on pregnancy outcomes in infertile women with genital tuberculosis compared with not receiving antituberculosis treatment or receiving the treatment for a shorter period. DATA EXTRACTION AND SYNTHESIS: Two independent reviewers extracted data. We used Cochrane Risk of Bias 1.0 and Risk Of Bias In Non-randomised Studies tools for risk of bias assessment and meta-analysis was not performed. We used Grading of Recommendations, Assessment, Development and Evaluations approach to assess the certainty of the evidence. RESULTS: Two RCTs and one non-RCT were included. The antituberculosis regimens were based on isoniazid, rifampicin, pyrazinamide and ethambutol for 6-12 months. In women without structural damage, very low certainty of evidence from one RCT showed that the antituberculosis treatment may have little to no effect on pregnancy, full-term pregnancy, abortion or intrauterine death and ectopic pregnancy, but the evidence is very uncertain. In women with structural damage, very low certainty of evidence from one non-RCT showed that the antituberculosis treatment may reduce the pregnancy rate (297 fewer per 1000, 95% CI -416 to -101), but the evidence is very uncertain. In addition, very low certainty of evidence from one RCT compared a 9-month vs 6-month antituberculosis treatment regimen showed similar effects between the schemes, but the evidence is very uncertain. Two RCTs reported that no adverse events of antituberculosis treatment were noted or were similar in both groups. CONCLUSION: The effect of antituberculosis treatment on pregnancy outcomes in infertile women with genital tuberculosis is very uncertain. PROSPERO REGISTRATION NUMBER: CRD42022273145.


Assuntos
Infertilidade Feminina , Tuberculose , Feminino , Gravidez , Humanos , Resultado da Gravidez , Natimorto , Infertilidade Feminina/tratamento farmacológico , Infertilidade Feminina/etiologia , Antituberculosos/uso terapêutico , Genitália
3.
Data Brief ; 36: 107066, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-34013007

RESUMO

This article presents a dataset of raw microscopic images of the prefrontal cortex from wistar rat tissues, after an induced stroke, stained with NeuN antibody. The raw images were captured using a microscope equipped with a digital camera. The dataset is useful for testing techniques for the improvement, registration, and stitching to generate a high-resolution image with a full reconstruction of tissues. Besides, this dataset can be used to assess the neuronal brain after an ischemic event. The dataset contains 1370 microscope images with 20x magnification and 36 (Hierarchical Data Format version 5) hdf5 files with homography matrices between every pair of sequential images per tissue rows.

4.
Colomb Med (Cali) ; 47(2): 87-93, 2016 Jun 30.
Artigo em Inglês | MEDLINE | ID: mdl-27546930

RESUMO

OBJECTIVE: To evaluate transcallosal changes after a local ischemic injury in rats by using the monoclonal marker anti-NeuN (Mouse anti-neuronal nuclei). METHODS: Twenty-eight adult, male, Wistar rats were subjected to focal injury in the right hemisphere. The technique used was the experimental model of focal ischemic injury through intraluminal suture of the middle cerebral artery. Analyses were made for the five groups: after the lesion (control), at 24 h, 96 h, 10 days and 20 days. Exofocal neuronal damage was inferred from neuronal immunoreactivity changes to NeuN. RESULTS: In the cortex contralateral to the lesion, immunoreactivity was diminished. This finding was most notable in the supra-granular sheets 24 h post ischemia. After 96 h, there was a generalized diminishment of the inmmunoreactivity in the supra and infra-granular sheets. At 10 and 20 days, the tissue recovered some immunoreactivity to NeuN, but there were some changes in the VI layer. CONCLUSION: The immunoreactive changes to NeuN support the process of inter-hemispheric diaschisis. Changes in immunoreactivity could indicate metabolic stress secondary to the disruption in connectivity to the site of lesion.


OBJETIVO: Evaluar los cambios exofocales transcallosos después de lesión isquémica focal en ratas, mediante marcación inmunohistoquímica con el anticuerpo monoclonal anti-NeuN (Mouse Anti-Neuronal Nuclei). MÉTODOS: Se intervinieron 28 ratas machos Wistar adultas. Mediante el modelo experimental de isquemia cerebral focal del territorio de la arteria cerebral media por filamento intraluminal, se les ocasionó una lesión focal en el hemisferio derecho. Posteriormente se evaluó el hemisferio contralateral, marcando la población neuronal con el anticuerpo monoclonal anti-NeuN. Se definieron cinco grupos de evaluación: uno de control, 24 horas, 96 horas, 10 días y 20 días. Se evaluaron los cambios neuronales exofocales después de la lesión con base en la observación de los cambios en la inmunoreactividad de las neuronas al NeuN. RESULTADOS: Se redujo la inmunoreactividad en la corteza contralateral a la lesión. Este fenómeno fue más notable en las capas supragranulares después de 24 h post isquemia. Después de 96 h hubo una disminución generalizada de la inmmunoreactivity en las capas supra e infragranulares. A los 10 y 20 días, el tejido recobró alguna inmunoreactividad NeuN, estos cambios se dieron en la capa VI. CONCLUSIONES: Los cambios inmunorreactivos a NeuN apoyan el proceso de diasquisis interhemisférica. Los cambios en la inmunorreactividad podrían indicar estrés metabólico secundario a la interrupción en la conectividad con el sitio de la lesión.


Assuntos
Antígenos Nucleares/análise , Isquemia Encefálica/complicações , Corpo Caloso/patologia , Artéria Cerebral Média , Animais , Anticorpos Monoclonais , Antígenos Nucleares/imunologia , Biomarcadores , Isquemia Encefálica/patologia , Corpo Caloso/imunologia , Imuno-Histoquímica , Masculino , Necrose , Ratos , Ratos Wistar
5.
Agora USB ; 19(2): 404-423, jul.-dic. 2019. tab
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1054785

RESUMO

Resumen Los expertos como los empresarios no perciben de manera optimista la innovación y la competitividad, en tanto las condiciones actuales no permitirán al empresariado responder a las expectativas nacionales del desarrollo en el contexto del postconflicto. De esta manera, no es suficiente con una baja absorción tecnológica y uso de computadores, es preocupante la baja percepción que se tiene de la ética del gobierno y de las firmas y la propiedad intelectual, así como la calidad de los puertos y aeropuertos, es baja la percepción del comercio exterior, así como de la sofisticación del mercado financiero, la protección al inversionista y la regulación de intercambios. Puede decirse que en este panorama las pymes colombianas no podrán responder a los desafíos del postconflicto como se propone a partir de la política pública y de los programas gubernamentales. Clasificación JEL: D41, O32, O14, D74


Abstract Experts such as entrepreneurs do not optimistically perceive innovation and competitiveness, while the current conditions will not allow entrepreneurs to respond to national development expectations in the post-conflict context. In this way, it is not enough with a low technological absorption and use of computers. It is worrying the low perception of the ethics of government and signatures, and the intellectual property, as well as the quality of ports and airports, the perception foreign trade is low, as well as the financial market sophistication, investor protection, and trade regulation. It can be said that in this Colombian context, SMEs will not be able to respond to the challenges of post-conflict as it is proposed, based on public policy and government programs. JEL Classification Codes: D41, O32, O14, D74

6.
Colomb. med ; 47(2): 87-93, Apr.June 2016. ilus
Artigo em Inglês | LILACS | ID: lil-791144

RESUMO

Objective: To evaluate transcallosal changes after a local ischemic injury in rats by using the monoclonal marker anti-NeuN (Mouse anti-neuronal nuclei). Methods: Twenty eight adult, male, Wistar rats were subjected to focal injury in the right hemisphere. The technique used was the experimental model of focal ischemic injury through intraluminal suture of the middle cerebral artery. Analyses were made for the five groups: and after the lesion (control), at 24 h, 96 h, 10 days and 20 days. Exofocal neuronal damage was inferred from neuronal immunoreactivity changes to NeuN. Results: In the cortex contralateral to the lesion, immunoreactivity was diminished. This was most notable in the supragranular layers 24 h post ischemia. After 96 h, there was a generalized diminishment of the inmmunoreactivity in supra and infragranular layers. At 10 and 20 days, the tissue recovered some NeuN immunoreactivity, but there were set changes in the VI layer. Conclusion: The immunoreactive changes to NeuN support the process of interhemispheric diaschisis. Changes in immunoreactivity could indicate metabolic stress secondary to the disruption in connectivity to the site of lesion.


Objetivo: Evaluar los cambios exofocales transcallosos después de lesión isquémica focal en ratas, mediante marcación inmunohistoquímica con el anticuerpo monoclonal anti-NeuN (Mouse Anti-Neuronal Nuclei). Métodos: Se intervinieron 28 ratas machos Wistar adultas. Mediante el modelo experimental de isquemia cerebral focal del territorio de la arteria cerebral media por filamento intraluminal, se les ocasionó una lesión focal en el hemisferio derecho. Posteriormente se evaluó el hemisferio contralateral, marcando la población neuronal con el anticuerpo monoclonal anti-NeuN. Se definieron cinco grupos de evaluación: uno de control, 24 h, 96 h, 10 días y 20 días. Se evaluaron los cambios neuronales exofocales después de la lesión con base en la observación de los cambios en la inmunoreactividad de las neuronas al NeuN. Resultados: Se redujo la inmunoreactividad en la corteza contralateral a la lesión. Este fenómeno fue más notable en las capas supragranulares después de 24 h post isquemia. Después de 96 h hubo una disminución generalizada de la inmmunoreactivity en las capas supra e infragranulares. A los 10 y 20 días, el tejido recobró alguna inmunoreactividad NeuN, estos cambios se dieron en la capa VI. Conclusiones: Los cambios inmunorreactivos a NeuN apoyan el proceso de diasquisis interhemisférica. Los cambios en la inmunorreactividad podrían indicar estrés metabólico secundario a la interrupción en la conectividad con el sitio de la lesión.


Assuntos
Animais , Masculino , Ratos , Isquemia Encefálica/complicações , Corpo Caloso/patologia , Artéria Cerebral Média , Antígenos Nucleares/análise , Imuno-Histoquímica , Biomarcadores , Isquemia Encefálica/patologia , Ratos Wistar , Corpo Caloso/imunologia , Antígenos Nucleares/imunologia , Anticorpos Monoclonais , Necrose
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA